Silence Therapeutics (SLN) Enterprise Value (2018 - 2026)
Silence Therapeutics recorded quarterly Enterprise Value of -$70.1 million in Q1 2026, up 17.67% quarter-over-quarter from -$85.1 million in Q4 2025, and up 48.67% year-over-year from -$47.1 million in Q1 2025.
Silence Therapeutics' Enterprise Value history runs 9 years deep, the most recent figure standing at -$70.1 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 48.67% year-over-year to -$70.1 million; the TTM figure through Mar 2026 stood at -$70.1 million (up 48.67% YoY), while the FY2025 annual figure was -$85.1 million, up 54.26% from the prior year.
- Enterprise Value came in at -$70.1 million for Q1 2026 at Silence Therapeutics, up from -$85.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$62.8 million in Q2 2023 to a low of -$193.8 million in Q1 2024.
- A 5-year average of -$108.6 million and a median of -$85.1 million in 2025 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value slumped 200.46% in 2024 and jumped 54.26% in 2025, its largest moves.
- Silence Therapeutics' Enterprise Value stood at -$68.4 million in 2022, then increased by 1.44% to -$67.4 million in 2023, then tumbled by 176.01% to -$186.1 million in 2024, then surged by 54.26% to -$85.1 million in 2025, then gained by 17.67% to -$70.1 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$70.1 million, -$85.1 million, and -$102.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | -70.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.08 Mn |
| Dec 31, 2025 | -85.11 Mn |
| Sep 30, 2025 | -102.19 Mn |
| Jun 30, 2025 | -114.16 Mn |
| Mar 31, 2025 | -136.53 Mn |
| Dec 31, 2024 | -186.07 Mn |
| Sep 30, 2024 | -167.60 Mn |
| Jun 30, 2024 | -188.82 Mn |
| Mar 31, 2024 | -193.77 Mn |
| Dec 31, 2023 | -67.41 Mn |
| Sep 30, 2023 | -74.86 Mn |
| Jun 30, 2023 | -62.84 Mn |
| Mar 31, 2023 | -76.41 Mn |
| Dec 31, 2022 | -68.40 Mn |
| Sep 30, 2022 | -106.42 Mn |
| Jun 30, 2022 | -65.32 Mn |
| Mar 31, 2022 | -79.97 Mn |
| Dec 31, 2021 | -99.53 Mn |
| Sep 30, 2021 | -98.94 Mn |
| Jun 30, 2021 | -99.99 Mn |
| Mar 31, 2021 | -63.05 Mn |
| Dec 31, 2020 | -38.22 Mn |
| Sep 30, 2020 | -17.96 Mn |
| Jun 30, 2020 | -13.18 Mn |
| Dec 31, 2019 | -17.38 Mn |
| Jun 30, 2019 | -14.81 Mn |
| Dec 31, 2018 | -27.66 Mn |